Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes

AuthorsCamillo, CA.
Langer, D.
Osadnik, CR.
Pancini, L.
Demeyer, H.
Burtin, C.
Gosselink, R.
Decramer, M.
Janssens, W.
Troosters, T
TypeJournal Article (Original Research)
JournalInternational Journal of Chronic Obstructive Pulmonary Disease
Year of Publication2016
URLhttps://www.dovepress.com/survival-after-pulmonary-rehabilitation-in-patients-with-copd-impact-o-peer-reviewed-article-COPD
DOIhttps://doi.org/10.2147/COPD.S113450
AbstractThe impact of rehabilitation-induced changes in 6-minute walk distance (6MWD) on the survival of patients with chronic obstructive pulmonary disease (COPD) has not been fully elucidated. This study sought to determine the association of baseline 6MWD and its changes after pulmonary rehabilitation (PR) with 5-year survival in patients with COPD. Patients who were referred to a 12-week outpatient PR program were followed up for 5 years postcompletion, and survival status was verified. Survival was analyzed according to four groups based upon initial 6MWD (6MWDi) and its changes (Δ6MWD) after PR (Group 1: 6MWDi ≥350 m and Δ6MWD ≥30 m; Group 2: 6MWDi ≥350 m and Δ6MWD <30 m; Group 3: 6MWDi <350 m and Δ6MWD ≥30 m; and Group 4: 6MWDi <350 m and Δ6MWD <30 m) via Kaplan-Meier analysis and log rank test. Cox regression was performed to identify possible confounders of mortality estimates. In total, 423 patients (with mean ± standard deviation of forced expiratory volume in the first second [FEV1] 43±16% predicted, age 65±8 years, and 6WMDi 381±134 m) underwent PR between 1999 and 2010. Survival rates decreased progressively from Group 1 to Group 4 (Group 1, 81%; Group 2, 69%; Group 3, 47%; Group 4, 27%; log rank test, P<0.05). 6MWDi ≥350 m (hazard ratio [HR] 0.39 [95% confidence interval {CI} 0.30-0.50]) and Δ6MWD ≥30 m (HR 0.66 [95% CI 0.51-0.85]) were strongly and independently associated with survival. Compared with Group 1, mortality risks progressively increased in Group 2 (HR 1.36 [95% CI 0.92-2.00]; not significant), Group 3 (HR 1.90 [95% CI 1.28-2.84]; P=0.001), and Group 4 (HR 3.28 [95% CI 2.02-5.33]; P,0.0001). Both poor 6MWD and lack of improvement >30 m after PR are associated with worse 5-year survival in patients with COPD

http://www.ibas.org.au/what-we-do/publications/3872876


< More publications



Shift work and breastfeeding projectSHIFT WORK AND BREASTFEEDING PROJECT

Researchers at Austin Health are looking for volunteers to participate in a study exploring the impact shift work has on breast milk composition. Participants will be compensated with a $100 gift voucher.

ARIELARIEL

Interstitial lung disease (ILD) is a chronic lung condition that causes stiff lungs and restricts sufferers from taking a deep breath. Exercise in a gym, or swimming, walking or riding a bike, can help...

HEALTHY MALES AND FEMALES WANTED FOR SLEEP STUDYHEALTHY MALES AND FEMALES WANTED FOR SLEEP STUDY

Interested to participate in a study investigating the effect of fatigue on driving performance?

A/Prof Mark Howard Awarded Major Competitive MRFF GrantA/PROF MARK HOWARD AWARDED MAJOR COMPETITIVE MRFF GRANT

IBAS leads project to revolutionize Home Ventilation with $1.2 million grant for Assoc. Prof Mark Howard's research titled "Synchronise non-invasive ventilation at home".

Prof Anne Holland receives prestigious Research AwardPROF ANNE HOLLAND RECEIVES PRESTIGIOUS RESEARCH AWARD

Prof Anne Holland receives prestigious award for Excellent in Research Engagement and Impact from Monash University.

World Sleep Day on 17th March 2023WORLD SLEEP DAY ON 17TH MARCH 2023

The benefits of quality sleep and to acknowledge the issue of sleep problems and their medical, educational, and social aspects as well as the prevention and management of sleep disorders, is promoted on World Sleep Day on the 17th March 2023.

A/Prof Mark Howard is listed in 'the Australian'A/PROF MARK HOWARD IS LISTED IN 'THE AUSTRALIAN'

The Australian's Research magazine names the top researcher and top research institution in each field of research, based on the number of citations for papers published in the top 20 journals in each field over the past five years.

Institute for Breathing and Sleep

Level 5, Harold Stokes Building, Austin Health
145 Studley Road
Heidelberg, Victoria, 3084

(03) 9496 5390

Email Us

Donate